{
    "title": "Alnylam's gene-silencing efforts get $2 bln Blackstone backing",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8214143/Blackstone-invests-2-bln-Alnylam-boosting-gene-silencing-drug-development.html",
    "date": "2020-04-13",
    "keywords": [
        "alnylam",
        "equity",
        "deal",
        "rnai",
        "joseph",
        "drugmaker",
        "stock",
        "technology",
        "coronavirus",
        "funding",
        "inclisiran",
        "year",
        "blackstone",
        "firm",
        "stake",
        "group",
        "inc",
        "monday",
        "boost",
        "approval",
        "treatment",
        "nobel",
        "interference",
        "range",
        "bleeding",
        "month",
        "company",
        "biotechnology",
        "giant",
        "exchange",
        "half",
        "therapy",
        "review",
        "street",
        "balance",
        "sheet",
        "time",
        "investment",
        "risk",
        "raise",
        "table",
        "cantor",
        "analyst",
        "alethia",
        "client",
        "note",
        "term",
        "loan",
        "debt",
        "turmoil",
        "morning",
        "trade",
        "financing",
        "beginning",
        "period",
        "uncertainty",
        "volatility",
        "officer",
        "john",
        "maraganore",
        "conference",
        "call",
        "royalty",
        "spread",
        "part",
        "class",
        "protein",
        "pcsk9",
        "novartis",
        "ag",
        "holder",
        "end",
        "material",
        "production",
        "sibi",
        "bengaluru",
        "editing",
        "soni",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}